Aurobindo Pharma Limited (NSE:AUROPHARMA)
India · Delayed Price · Currency is INR 1,621.30
+13.30 (0.83%)
Aug 21, 2026, 3:14 PM IST
Aurobindo Pharma Stock Forecast
Stock Price Forecast
According to 28 analysts polled by S&P Global, Aurobindo Pharma stock has a consensus rating of "Buy" and an average price target of ₹1,678. The average 1-year stock price forecast is 3.52% higher than the current stock price, while the lowest is ₹1,270 (-21.67%) and the highest is ₹1,955 (+20.58%).
Price Target: ₹1,678 (+3.52%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Aurobindo Pharma stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 14 | 15 | 13 | 13 | 13 | 13 |
| Buy | 6 | 6 | 6 | 6 | 6 | 5 |
| Hold | 1 | 1 | 5 | 5 | 5 | 5 |
| Sell | 2 | 2 | 2 | 2 | 2 | 2 |
| Strong Sell | 2 | 2 | 2 | 2 | 2 | 2 |
| Total | 25 | 26 | 28 | 28 | 28 | 27 |
Financial Forecast
Revenue This Year
400.33B
from 336.53B
Increased by 18.96%
Revenue Next Year
443.21B
from 400.33B
Increased by 10.71%
EPS This Year
79.47
from 61.11
Increased by 30.04%
EPS Next Year
92.98
from 79.47
Increased by 17.00%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.